These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17113397)

  • 21. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.
    Costanzo MR; Saltzberg M; O'Sullivan J; Sobotka P
    J Am Coll Cardiol; 2005 Dec; 46(11):2047-51. PubMed ID: 16325040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
    Freda BJ; Slawsky M; Mallidi J; Braden GL
    Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diuretic therapy in heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F;
    Med Clin (Barc); 2014 Feb; 142(4):163-70. PubMed ID: 23768854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms and management of diuretic resistance in congestive heart failure.
    De Bruyne LK
    Postgrad Med J; 2003 May; 79(931):268-71. PubMed ID: 12782772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of diuretics in the treatment of heart failure in the elderly.
    Sica DA; Gehr TW; Frishman WH
    Clin Geriatr Med; 2007 Feb; 23(1):107-21. PubMed ID: 17126757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Failing diuretics in severe chronic heart failure].
    Dormans TP; Gerlag PG; Smits P
    Ned Tijdschr Geneeskd; 1997 Jul; 141(30):1465-8. PubMed ID: 9542878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?
    Singh A; Blackwell J; Neher J
    J Fam Pract; 2005 Apr; 54(4):370-2. PubMed ID: 15833232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic therapy in heart failure: current controversies and new approaches for fluid removal.
    Brandimarte F; Mureddu GF; Boccanelli A; Cacciatore G; Brandimarte C; Fedele F; Gheorghiade M
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):563-70. PubMed ID: 20186069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we improve diuretic response in heart failure?
    Trelawny JM
    Br J Hosp Med; 1996 May 15-Jun 4; 55(10):616-9. PubMed ID: 8762118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diuretics in the treatment of patients who present congestive heart failure and hypertension.
    Reyes AJ
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S104-13. PubMed ID: 11986906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update of diuretics in the treatment of hypertension.
    Padilla MC; Armas-Hernández MJ; Hernández RH; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):154-60. PubMed ID: 17414583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating Diuretic Resistance: An Overview.
    Bowman BN; Nawarskas JJ; Anderson JR
    Cardiol Rev; 2016; 24(5):256-60. PubMed ID: 27465540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.
    Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do diuretics differ in terms of clinical outcome in congestive heart failure?
    Follath F
    Eur Heart J; 1998 Dec; 19 Suppl P():P5-8. PubMed ID: 9886706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diuretic usage in heart failure: a continuing conundrum in 2005.
    Gupta S; Neyses L
    Eur Heart J; 2005 Apr; 26(7):644-9. PubMed ID: 15734765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.